Dietrich, P., Gaza, A., Wormser, L., Fritz, V., Hellerbrand, C., & Bosserhoff, A. K. (2019). Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma(). Neoplasia.
Styl cytowania ChicagoDietrich, Peter, Anne Gaza, Laura Wormser, Valerie Fritz, Claus Hellerbrand, i Anja Katrin Bosserhoff. "Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()." Neoplasia 2019.
Styl cytowania MLADietrich, Peter, et al. "Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()." Neoplasia 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..